Ozempic Linked to Increased Risk of Blindness
STORY AT-A-GLANCE Ozempic and Wegovy, GLP-1 receptor agonists, are successful weight loss drugs. However, research suggests they may increase the risk of gastrointestinal issues and potentially impact vision that may lead to blindness A 2024 study found an association between semaglutide (Ozempic) and non-arteritic anterior ischemic optic neuropathy (NAION) in diabetic and obese patients, potentially […]
Discuss on Nostr!
Nostr Note ID note1tp2psx6z4hy8arvpsk5qkqdguajjml48pdd9wd6qgrxxpr86q6nqzps8nh Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.